DocMorris AG (XSWX:DOCM) Stock Based Compensation: CHF0 Mil (TTM As of Jun. 2025)


XSWX:DOCM DocMorris AG XSWX:DOCM
65 GF Score
Price CHF8.15
GF Value CHF10.53
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is DocMorris AG Stock Based Compensation?

DocMorris AG XSWX:DOCM +2.97% 65 Stock Based Compensation is CHF0 Mil as of Jun. 2025. GuruFocus rates XSWX:DOCM with a GF Score™ of 65/100 and a GF Value™ of CHF10.53 (Modestly Undervalued). The stock has 8 warning signs investors should review.

DocMorris AG's Stock Based Compensation for the six months ended in Jun. 2025 was CHF0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2025 was CHF0 Mil.

DocMorris AG Stock Based Compensation Related Terms

DocMorris AG Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for DocMorris AG's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DocMorris AG Stock Based Compensation Chart

DocMorris AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

DocMorris AG Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XSWX:DOCM
65GF Score
DocMorris AG XSWX:DOCM
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DocMorris AG Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF0 Mil.

What does a Stock Based Compensation of CHF0 Mil mean?
DocMorris AG (XSWX:DOCM) has a Stock Based Compensation of CHF0 Mil as of Jun. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for DocMorris AG and its competitors.
Is DocMorris AG's Stock Based Compensation too high?
DocMorris AG's current Stock Based Compensation is CHF0 Mil. Overall, DocMorris AG has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DocMorris AG's Stock Based Compensation compare to competitors?
DocMorris AG's Stock Based Compensation of CHF0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for DocMorris AG and its competitors. DocMorris AG's current Stock Based Compensation is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocMorris AG stock overvalued right now?
Based on GuruFocus' analysis, DocMorris AG (XSWX:DOCM) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF10.53, compared to a current price of CHF8.15 — trading 22.6% below its estimated fair value. The current Stock Based Compensation is CHF0 Mil. DocMorris AG's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For DocMorris AG (XSWX:DOCM), the current Stock Based Compensation is CHF0 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DocMorris AG (XSWX:DOCM) Overvalued in 2026?

Based on GuruFocus' analysis, DocMorris AG stock appears to be undervalued. The current stock price of CHF8.15 is trading 22.6% below its estimated GF Value™ of CHF10.53. GuruFocus considers DocMorris AG to be Modestly Undervalued.

Key valuation signals for XSWX:DOCM:

  • Stock Based Compensation: CHF0 Mil
  • GF Value™: CHF10.53 vs. price of CHF8.15 (22.6% below fair value)
  • GF Score™: 65/100 with 8 warning signs

No single metric tells the full story. See the XSWX:DOCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DocMorris AG Business Description

Other Exchanges DOCMz:UK0RRB:UKZRE:Germany
Address Walzmuhlestrasse 49, Frauenfeld, CHE, 8500
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
65GF Score

Get the complete analysis for XSWX:DOCM

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF8.15
Price
CHF10.53
GF Value